Overview

Schizophrenia Study In Adults

Status:
Completed
Trial end date:
2003-04-01
Target enrollment:
Participant gender:
Summary
A Placebo Controlled Study For Patients With Schizophrenia
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Risperidone